NewsCryptoInjective Analyst Sets $14 Target After Cup-and-Handle Breakout as RWA Markets Reach 135

Injective Analyst Sets $14 Target After Cup-and-Handle Breakout as RWA Markets Reach 135

Author: Cryptofrontnews·

Key Takeaways

  • •INJ reached $8.871 on October 17, 2026, gaining more than 30% since breaking out of a cup-and-handle pattern, with analyst Ali Charts projecting a target near $14.
  • •The token trades above its 50-day moving average near $7.83 and its 200-day average around $7.43, with resistance between $9.00 and $9.30 and initial support at $8.50.
  • •Injective operates 135 live onchain real-world asset markets holding more than $1 billion in tokenized assets, with cumulative RWA trading volume exceeding $6.8 billion.
  • •Institutional adoption spans South Korea, Japan, and Thailand, including POSCO International and LG CNS tokenizing trade receivables, Nomura's Laser Digital tokenizing its Laser Carry Fund, and Gulf Labs bonding roughly 500,000 INJ as a validator.
  • •Three INJ ETF applications remain pending with the SEC, regulated INJ futures trade under CFTC oversight, and the INJ MiCA white paper appears on ESMA's register.
Injective Analyst Sets $14 Target After Cup-and-Handle Breakout as RWA Markets Reach 135

Injective (INJ) climbed to $8.871 on October 17, 2026, after a sustained recovery from its mid-August levels, while analyst Ali Charts projects a potential move toward $14. The token has already gained more than 30% since breaking out of a cup-and-handle pattern, and the network behind it now reports 135 live onchain real-world asset (RWA) markets alongside expanding institutional activity.

Ali Charts Sets $14 Target After Breakout

According to Ali Charts in a post on X, INJ broke out of a cup-and-handle formation and has gained more than 30% from its breakout point. The pattern projects a target near $14, although the price must first advance beyond current resistance levels.

INJ rose from approximately $4 in mid-August, then moved above $6 and $8 as the recovery progressed. The latest leg higher approached $9.30 before a slight pullback. Trading volume has risen alongside the advance, with a recent spike toward approximately 300 million INJ.

The token currently trades above its 50-day moving average near $7.83 and its 200-day average around $7.43, and the 50-day average also remains above the 200-day average. Resistance between $9.00 and $9.30 could challenge further gains, while $8.50 provides initial support. How price behaves around that resistance band is the immediate technical test between the current level and the pattern's $14 projection.

Injective Reports 135 Live RWA Markets

Beyond price action, Injective reports 135 live onchain real-world asset markets and more than $1 billion in tokenized assets. Markets covering SpaceX, OpenAI, equities, foreign exchange, and digital asset treasuries have generated over $6.8 billion in cumulative RWA trading volume. For a sector frequently discussed in terms of future potential, those are realized volumes on live markets.

Institutional adoption continues to broaden the network's tokenization ecosystem. In South Korea, POSCO International and LG CNS selected Injective to tokenize trade receivables from international commerce. In Japan, Laser Digital, part of Nomura, tokenized its Laser Carry Fund alongside BlackRock money market products and Hamilton Lane's SCOPE Senior Credit Fund. These products support onchain secondary trading, collateralized lending, and portfolio margining. The mix of participants — an incumbent Japanese brokerage group alongside names tied to BlackRock and Hamilton Lane — mirrors the broader industry shift in which traditional finance institutions are moving tokenized fund structures onto blockchain infrastructure.

On the regulatory front, Injective Institutional Services is now an SEC-registered transfer agent, and the INJ MiCA white paper appears on ESMA's register. Three INJ ETF applications remain pending with the SEC, while regulated INJ futures are live under the oversight of the U.S. Commodity Futures Trading Commission (CFTC). Taken together, these touchpoints place INJ-linked products within recognized regulatory frameworks in both the United States and the European Union, which is what gives the pending ETF applications significance beyond the price chart.

Institutional Expansion Adds More Network Developments

Gulf Labs, part of Thailand's $27 billion GULF Group, bonded roughly 500,000 INJ as an institutional validator. The group plans to bring tokenization and stablecoins to Thailand's energy, telecom, and banking sectors, extending the network's institutional footprint into Southeast Asia alongside its existing South Korean and Japanese engagements.

Injective CEO Eric Chen met with senior White House, SEC, and CFTC officials this week to advance U.S. tokenization efforts. Separately, NTT Digital selected Injective as its primary blockchain partner, and Musicow partnered with the network to bring music intellectual property onchain. Musicow counts 1.2 million members and approximately 20,000 traded music rights.

Native USDC on Injective supports payments to more than 8,000 global merchants, with Circle's Cross-Chain Transfer Protocol (CCTP) connecting the network to more than 20 blockchains. Injective Mint is also planned, with protocol-level compliance controls for institutional real-world assets. With three ETF applications pending at the SEC and Injective Mint still ahead, the network has concrete milestones that can be tracked alongside the chart's key levels.